The Presidencies’ perspective on the pharmaceutical strategy: Europe’s to-do list on access to medicines

25 November 2020

16:00-17:00 CET

Online

Our fourth dialogue in a series of online discussions on key access to medicines (A2M) priorities bringing together thought leaders and policy-makers, academics, industry representatives and NGOs, for a frank discussion of European pharmaceutical policies.

Take part in our #A2MDialogues to share your questions and ideas and help us develop actionable #A2Msolutions for decision-makers in Europe.

 

Following the publication of the EU’s Pharmaceutical Strategy by the European Commission, senior representatives of the upcoming EU Presidencies (Portugal & Slovenia) and the Netherlands offer their perspective on what should be prioritised and debate next steps in European pharmaceutical policy.

Panellists

Rui Ivo Santos

Rui Ivo Santos

President INFARMED, Portugal

Momir Radulović

Momir Radulović

Executive Director, Slovenian Medicines Agency

Marcel van Raaij

Marcel van Raaij

Director Medicines & Medical Technologies, Dutch Ministry of Health

Moderated by

Yannis Natsis

Yannis Natsis

EPHA

Panelists

Rui Ivo Santos  

President

INFARMED, Portugal

 

Momir Radulovic

Executive Director

Slovenian Medicines Agency

Marcel van Raaij

Director

Medicines & Medical Technologies

Dutch Ministry of Health

#A2MDialogues

EPHA’s series of online discussions on key access to medicines (A2M) priorities brings together thought leaders and policy-makers, academics, industry representatives and NGOs, for a frank discussion of European pharmaceutical policies.

Get involved !

Get involved !

Sign up here to receive our updates on European health policy and invitations to our events.

Subscribe now

You have Successfully Subscribed!

Share This